
The journal retracts the article titled “Synthesis of Stabilized Myrrh-Capped Hydrocolloidal Magnetite Nanoparticles” [...]
The Journal retracts the article “Hybrid Ionic Silver and Magnetite Microgels Nanocomposites for Efficient Removal of Methylene Blue” [...]
The overuse of antibiotics in aquaculture has accelerated the emergence of drug-resistant bacteria and biofilm-associated infections, creating an urgent need for alternative antimicrobial agents. Zinc oxide nanoparticles (ZnO NPs) are promising candidates owing to their low toxicity and cost, but their intrinsic antibacterial activity is often inadequate. Herein, we report a series of copper-doped ZnO nanoparticles (Cu@ZnO NPs, 1–5 mol% Cu) synthesized via a facile solvothermal method. The 2% Cu@ZnO NPs, comprising well-dispersed spherical particles of approximately 200 nm with a highly positive surface charge (+20 mV), exhibited the strongest antibacterial activity, outperforming pristine and commercial ZnO, with a minimum inhibitory concentration (MIC) of 0.2 mg/mL and a minimum bactericidal concentration (MBC) of 1.0 mg/mL against both Escherichia coli and Staphylococcus aureus. Mechanistic studies suggested that bactericidal activity may arise from the synergy of electrostatic adsorption, membrane disruption accompanied by protein leakage, intracellular reactive oxygen species (ROS) generation, and sustained metal-ion release. The nanoparticles were shown to reduce biofilm formation by 80.96% and maintained 88.4% viability of L929 fibroblasts at 20 μg/mL, indicating good biocompatibility. In a zebrafish larvae infection model, 5.0 μg/mL of 2% Cu@ZnO increased the 72 h survival rate from 6.25% (Vibrio-challenged) to 65.0%. Cu@ZnO-loaded filter materials further demonstrated practical applicability for aquaculture water pretreatment. This work elucidates the structure–activity relationship of Cu-doped ZnO nanomaterials and offers a low-toxicity, filter-integrable alternative to antibiotics for sustainable aquaculture.
A series of complexes of copper(I) iodide with 1,4-thioxane, THX, were prepared and characterized by thermal, spectroscopic, computational, and crystallographic methods. The following compounds were reported: (CuI)4(THX)3 (1), (CuI)4(THX)4 (2), (CuI)3(THX)2(MeCN) (3), and (CuI)2(THX)4 (4). The bonding of the THX ligand to Cu(I) was observed exclusively through the sulfur atom. Compound 1 consisted of chains of Cu4I4 cubane tetramers by a μ2-S THX and with two terminal THX ligands. Compound 2 was a chain link polymer with Cu2I2 rhombs bridged by μ2-S THX ligands. Compound 3 was composed of open Cu4I4 tetramers bridged by pairs of THX ligands to form a ladder polymer. Compound 4 was a simple Cu2I2 rhombic dimer with two terminal THX ligands on each Cu atom. Compounds 2 and 3 contained Cu3(μ2-I)2S2 rings comprising a CuS2 vertex and a Cu2(μ2-I)2 base, which were linked to one another through Cu2(μ2-I)2 at the vertex Cu. The difference lies in the linkage to the Cu2(μ2-I)2 base, which consisted of MeCN and Cu2(μ2-I)2 in 2 and terminal THX ligands in 3. Compounds 1–4 were luminescent, showing quantum yields of 78, 24, 19, and 53%, respectively, and lifetimes of 4.88, 4.86, 4.68, and 5.48 μs. Diffuse reflectance revealed large optical bandgaps of 2.93–3.00 eV. The partial density of states results revealed excitation via mixed halide/metal-to-metal transition.
Lycopodium japonicum Thunb. (L. japonicum) is a traditional medicinal herb that functions to dispel wind-dampness, relax the tendons, and unblock the collaterals (qu feng chu shi and shu jin huo luo, typical TCM syndrome-oriented therapeutic concepts). Clinically, it is frequently prescribed for the management of arthralgia, rheumatic conditions, and orthopedic ailments. Up to now, a total of 177 chemical constituents have been isolated and structurally elucidated from L. japonicum. Among these, alkaloids and triterpenoids are considered principal bioactive constituents, which exert multiple pharmacological effects including antitumor, anti-inflammatory and acetylcholinesterase-inhibitory effects. Nevertheless, their contributions to the overall pharmacological activities still require further mechanistic validation. Recently, the spores of L. japonicum have emerged as a promising natural platform for targeted drug delivery. In parallel, analytical strategies for its quality control have evolved from single-marker quantification toward simultaneous multi-component determination. Nevertheless, several key issues, including the standardization of formulation protocols, mechanistic clarification of pharmacological actions, and robust quality control systems, still require systematic investigation and refinement. As a traditional herbal medicine, it has relatively limited data regarding its in vivo absorption, toxicology, pharmacokinetics, and clinical trials. This review systematically summarizes the research advances of L. japonicum in phytochemistry, pharmacological activities, and quality control. It also proposes evidence-based recommendations for addressing key issues in current research, including unclear chemical composition, poorly understood pharmacological mechanisms, and the absence of quality standards. This review aims to provide an updated reference for future phytochemical, pharmacological, toxicological, and quality-control research on L. japonicum.